PremiumThe FlyBiodexa says on track to initiate Phase 3 trial in FAP next quarter Biotech Alert: Searches spiking for these stocks today Biodexa Pharmaceuticals Advances Phase 3 eRapa Program with FDA Approval PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Biodexa Pharmaceuticals to Present at Emerging Growth Conference Biotech Alert: Searches spiking for these stocks today PremiumThe FlyBiodexa Pharmaceuticals files to sell 35.875M ADS for holders Biodexa Pharmaceuticals Secures Flexible $35 Million Funding Agreement Biodexa Pharmaceuticals price target raised to $18 from $8 at Ladenburg